BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...

July 13, 2021 | News

Biological E to purchase CpG 1018 adjuvant from Dynavax

DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...

July 06, 2021 | News

DCGI has approved biotechnology Panacea Biotech to manufacture Sputnik V in India.

The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India. The batches produced at Panacea Biotec’s faciliti...

July 05, 2021 | News

DHL Express delivers US donation of Pfizer-BioNTech vaccines to Malaysia

DHL Express, the world's leading logistics provider, has successfully delivered the United States government's donation of the Pfizer-BioNTech vaccine toda...

July 05, 2021 | News

J & J Single-Shot COVID-19 Vaccine shows Positive Data Against Delta Variant

Demonstrated strong neutralizing antibody activity against the Delta (B.1.617.2) variant Persistent immune responses through at least eight months Jo...

July 04, 2021 | News

Korea (KNIH) conducts field inspection of companies with mRNA technology

Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted...

July 02, 2021 | News

InDevR Launches VaxArray Polio Kit

InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeu...

July 01, 2021 | News

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

India cleared the 4th vaccine for emergency use in the country, the US-made Moderna.

Mumbai-based pharma major Cipla has been allowed to import Moderna's Covid vaccine for restricted emergency use in India, where the vaccines used so far we...

June 30, 2021 | News

mRNA Vaccine Technology Holds Promise, but Faces Challenges

Numerous studies and statistics from national governments also suggest the data looks good regarding how the mRNA vaccines perform against emerging variant...

June 24, 2021 | Opinion

Merck Receives Patent for Improved CRISPR Genome-Editing Method in Japan

Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions ...

June 23, 2021 | News

eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®

eTheRNA immunotherapies NV a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announ...

June 23, 2021 | News

Manufacturing Strategies for mRNA Vaccines and Therapeutics

In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...

June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

June 15, 2021 | News

Stay Connected